Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

Patients and data tracking

- PMLiVE

AstraZeneca’s Imfinzi/Lynparza regimens granted EC approval to treat endometrial cancer

Almost 125,000 new cases of endometrial cancer were diagnosed in Europe in 2022

- PMLiVE

Eli Lilly’s GIP/GLP-1 receptor agonist tirzepatide shown to significantly reduce type 2 diabetes risk

More than 5.6 million people in the UK are estimated to be living with a form of diabetes

- PMLiVE

J&J’s Rybrevant/Lazcluze combination approved by FDA as first-line lung cancer treatment

Non-small cell lung cancer accounts for up to 85% of all lung cancer cases

- PMLiVE

Measuring success: our key highlights from BrightonSEO

Attending BrightonSEO allows us to keep up to date with some of the latest developments and forward thinking in content marketing. It’s the biggest search marketing conference in the world,...

Wallace Health

- PMLiVE

Gilead’s Livdelzi receives FDA accelerated approval to treat primary biliary cholangitis

The company gained access to the drug through its $4.3bn acquisition of CymaBay in March

- PMLiVE

Pfizer shares promising phase 3 results for RSV vaccine in immunocompromised adults

There are currently no RSV vaccines approved for adults aged 18 to 59 years in the US

- PMLiVE

AstraZeneca’s Imfinzi regimen granted FDA approval to treat resectable lung cancer

Approximately 235,000 people are expected to be diagnosed with lung cancer in the US this year

- PMLiVE

minds + assembly appoints Fabio Gratton to board of directors

Gratton has 25 years of experience in founding and scaling healthcare digital agencies

- PMLiVE

Astellas’ Vyloy combination approved by MHRA as first-line gastric cancer treatment

Approximately 6,600 new cases of the disease are diagnosed in the UK every year

- PMLiVE

Opportunities and challenges from the rise of antibody drug conjugates

By Will Fazzone

- PMLiVE

Launching The Health House – a collaboration of 25 independent health agencies

The network seeks to raise standards across the healthcare communications landscape

- PMLiVE

Optimizing Patient Recruitment & Retention in Influenza Studies

With the flu season rapidly approaching, there is a surge in influenza and vaccine-related studies. These studies often face the significant challenge of a very short recruitment window, which necessitates...

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links